Financial Ratios

VEERHEALTH CARE LTD.

NSE : NABSE : 511523ISIN CODE : INE882C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE20.98-0.42 (-1.96 %)
PREV CLOSE ( ) 21.40
OPEN PRICE ( ) 20.98
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29222
TODAY'S LOW / HIGH ( )20.98 20.98
52 WK LOW / HIGH ( ) 9.3530.1
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.58-0.110.550.460.23
   CEPS(Rs)1.100.320.610.460.34
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)21.4320.1220.2519.8419.16
   Tax Rate(%)-41.64130.9834.2550.8058.20
Margin Ratios
   Core EBITDA Margin(%)3.70-8.62-0.595.797.37
   EBIT Margin(%)8.423.357.527.146.90
   Pre Tax Margin(%)8.412.475.455.526.32
   PAT Margin (%)11.92-0.763.582.712.64
   Cash Profit Margin (%)16.604.688.015.477.99
Performance Ratios
   ROA(%)6.97-0.382.071.861.02
   ROE(%)8.94-0.532.732.351.20
   ROCE(%)6.322.174.975.502.89
   Asset Turnover(x)0.580.500.580.690.39
   Sales/Fixed Asset(x)0.950.790.951.340.92
   Working Capital/Sales(x)1.422.562.012.5119.18
Efficiency Ratios
   Fixed Capital/Sales(x)1.051.261.050.751.09
   Receivable days46.4758.5042.7826.1350.68
   Inventory Days65.0371.8049.9132.2354.32
   Payable days56.8085.2942.5755.8284.79
Valuation Parameters
   PER(x)12.670.0013.9013.8332.87
   PCE(x)9.1017.596.226.8610.88
   Price/Book(x)0.940.570.380.320.39
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.240.780.650.591.00
   EV/Core EBITDA(x)9.458.885.465.928.13
   EV/EBIT(x)14.7023.318.688.2014.43
   EV/CE(x)0.650.370.370.380.37
   M Cap / Sales1.510.820.500.380.87
Growth Ratio
   Net Sales Growth(%)37.89-9.01-9.7995.9715.77
   Core EBITDA Growth(%)105.46-32.978.8858.3122.92
   EBIT Growth(%)246.51-59.42-5.02102.7128.46
   PAT Growth(%)2249.46-119.4119.13101.2015.39
   EPS Growth(%)1590.57-119.4119.14101.2015.40
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.120.180.07
   Current Ratio(x)10.612.534.344.131.12
   Quick Ratio(x)7.941.673.283.310.80
   Interest Cover(x)860.153.793.644.4011.97
   Total Debt/Mcap(x)0.000.000.330.560.18

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.